Alliance/Market LaunchBio Usawa becomes partner for the commercialization of FYB201/ BioUcenta™ (ranibizumab) across Sub-Saharan Africa 01.07.2025 / 13:15 CET/CESTThe issuer is solely responsible for ...

The European Commission has cleared the high-strength formulation of Eylea (aflibercept) with an extended treatment interval ...

Dry age-related macular degeneration is a gradual deterioration or thinning of the macula as the retinal cells die off and do not regenerate. Unfortunately, while there is currently no cure for dry ...

Historically, the most common treatment for wet macular degeneration (wAMD) involved anti-vascular endothelial growth factor (VEGF) injections, such as Avastin, Lucentis, and Eylea. These drugs work ...

Certain medications can be used to treat macular degeneration, although almost all available medications are specifically for age-related macular degeneration.

Medication is sometimes necessary to treat eye conditions and vision problems. Of course, this is highly dependent on the condition. Sometimes, the better option might be surgery, corrective wear, or ...

Dear Savvy Senior, Is macular degeneration hereditary? My mother lost much of her vision from it before she died, and now at age 65, I’m concerned I may get […] ...

Dear Savvy Senior: Is macular degeneration hereditary? My mother lost much of her vision from it before she died, and now at age 65, I’m concerned I may get it. What can you tell me? — Brown ...

Anti-VEGF treatments are the best available treatment for wet age-related macular degeneration (AMD). Learn how these injection medications can maintain and even improve vision in AMD patients.

There have been tremendous advances in treatment of several significant eye diseases, including macular degeneration, thyroid eye disease, eye infection.

Wet age-related macular degeneration (Wet AMD), or advanced neovascular AMD, is an eye condition affecting central vision that can cause rapid vision loss.

A new generation of gene therapies is poised to reshape the treatment of age-related macular degeneration by prompting the body to make its own anti-vascular endothelial growth factor (VEGF ...